BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22126783)

  • 1. [Pharmacokinetics of amphotericin B in the cerebrospinal fluid during continuous intrathecal administration for treatment of cryptococcal neoformans meningitis].
    Fang M; Lv TM; Yan Y; Liu ST; Gao WH; Liu XJ; Yin J; Wang L; Wang YY
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1929-31. PubMed ID: 22126783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cryptococcal meningitis successfully treated with liposomal amphotericin B and voriconazole in an elderly patient].
    Ogaki K; Noda K; Fukae J; Furuya T; Hirayama T; Fujishima K; Hattori N; Okuma Y
    Brain Nerve; 2010 Dec; 62(12):1337-40. PubMed ID: 21139187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphotericin B transfer to CSF following intravenous administration of liposomal amphotericin B.
    Strenger V; Meinitzer A; Donnerer J; Hofer N; Dornbusch HJ; Wanz U; Seidel MG; Sperl D; Lackner H; Schwinger W; Sovinz P; Benesch M; Urban C
    J Antimicrob Chemother; 2014 Sep; 69(9):2522-6. PubMed ID: 24891430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice.
    Xu N; Gu J; Zhu Y; Wen H; Ren Q; Chen J
    Int J Nanomedicine; 2011; 6():905-13. PubMed ID: 21720503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients.
    Manosuthi W; Chetchotisakd P; Nolen TL; Wallace D; Sungkanuparph S; Anekthananon T; Supparatpinyo K; Pappas PG; Larsen RA; Filler SG; Andes D;
    HIV Med; 2010 Apr; 11(4):276-81. PubMed ID: 20002501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B.
    Pitisuttithum P; Tansuphasawadikul S; Simpson AJ; Howe PA; White NJ
    J Infect; 2001 Nov; 43(4):226-33. PubMed ID: 11869059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus-associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial.
    Jarvis JN; Leeme TB; Molefi M; Chofle AA; Bidwell G; Tsholo K; Tlhako N; Mawoko N; Patel RKK; Tenforde MW; Muthoga C; Bisson GP; Kidola J; Changalucha J; Lawrence D; Jaffar S; Hope W; Molloy SLF; Harrison TS
    Clin Infect Dis; 2019 Jan; 68(3):393-401. PubMed ID: 29945252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
    Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
    J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics of continuous and conventional intrathecal amphotericin B in rabbits.
    Fang M; Lü TM; Ma AD; Wang L; Li GL; Qiu AZ; Pan ZY; Wang YY; Liu XJ
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5253-7. PubMed ID: 22850516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial.
    Bicanic T; Wood R; Meintjes G; Rebe K; Brouwer A; Loyse A; Bekker LG; Jaffar S; Harrison T
    Clin Infect Dis; 2008 Jul; 47(1):123-30. PubMed ID: 18505387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of intrathecal administration of liposomal amphotericin B combined with voriconazole in a murine model of cryptococcal meningitis.
    Gazzoni AF; Capilla J; Mayayo E; Guarro J
    Int J Antimicrob Agents; 2012 Mar; 39(3):223-7. PubMed ID: 22226648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal amphotericin B (Fungisome) for the treatment of cryptococcal meningitis in HIV/AIDS patients in India: a multicentric, randomized controlled trial.
    Jadhav MP; Bamba A; Shinde VM; Gogtay N; Kshirsagar NA; Bichile LS; Mathai D; Sharma A; Varma S; Digumarathi R
    J Postgrad Med; 2010; 56(2):71-5. PubMed ID: 20622383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A brain-vectored angiopep-2 based polymeric micelles for the treatment of intracranial fungal infection.
    Shao K; Wu J; Chen Z; Huang S; Li J; Ye L; Lou J; Zhu L; Jiang C
    Biomaterials; 2012 Oct; 33(28):6898-907. PubMed ID: 22789719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of antifungal drug levels in cerebrospinal fluid for cryptococcal meningoencephalitis.
    Shoji H; Takuma T; Ohbayashi H; Yoshida K; Yamamoto T; Niki Y
    J Infect Chemother; 2012 Oct; 18(5):775-9. PubMed ID: 22318291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous infusion of amphotericin B deoxycholate in the treatment of cryptococcal meningoencephalitis: analysis of safety and fungicidal activity.
    Falci DR; Lunardi LW; Ramos CG; Bay MB; Aquino VR; Goldani LZ
    Clin Infect Dis; 2010 Mar; 50(5):e26-9. PubMed ID: 20121575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis.
    Loyse A; Wilson D; Meintjes G; Jarvis JN; Bicanic T; Bishop L; Rebe K; Williams A; Jaffar S; Bekker LG; Wood R; Harrison TS
    Clin Infect Dis; 2012 Jan; 54(1):121-8. PubMed ID: 22052885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimum concentration of Amphotericin B in serum according to the formulation, dose, and daily or prolonged intermittent therapeutic regimen.
    Schiave LA; Nascimento E; Gaspar GG; Vilar FC; Martinez EZ; Gaitani CM; Martinez R
    Rev Soc Bras Med Trop; 2020; 53():e20180463. PubMed ID: 32049198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptococcal meningitis in immunocompetent children.
    Yuanjie Z; Jianghan C; Nan X; Xiaojun W; Hai W; Wanqing L; Julin G
    Mycoses; 2012 Mar; 55(2):168-71. PubMed ID: 21762212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of clinical isolates of Cryptococcus neoformans to amphotericin B using time-kill methodology.
    Pappalardo MC; Szeszs MW; Martins MA; Baceti LB; Bonfietti LX; Purisco SU; Baez AA; Melhem MS
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):146-51. PubMed ID: 19345042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of liposomal amphotericin B in patients with cryptococcal meningitis.
    Kotwani RN; Gokhale PC; Bodhe PV; Kirodian BG; Kshirsagar NA
    J Assoc Physicians India; 2001 Nov; 49():1086-90. PubMed ID: 11868862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.